Results 221 to 230 of about 32,298 (248)

<p>Can Standard Health Technology Assessment Approaches Help Guide the Price of Orphan Drugs in Canada? A Review of Submissions to the Canadian Agency for Drugs and Technologies in Health Common Drug Review</p>

ClinicoEconomics and Outcomes Research, 2020
Chakrapani Balijepalli, Jason Locklin, Lakshmi Gullapalli   +2 more
exaly  

Progress on Orphan Drugs

American Pharmacy, 1987
openaire   +2 more sources

Market uptake of orphan drugs - a European analysis

Journal of Clinical Pharmacy and Therapeutics, 2012
David Cassiman
exaly  

Affordable orphan drugs: a role for not‐for‐profit organizations

British Journal of Clinical Pharmacology, 2017
Dyfrig A Hughes
exaly  

Orphan drugs and orphan drug legislation

2013
openaire   +1 more source

International differences in patient access to ultra-orphan drugs

Health Policy and Technology, 2018
Tim Kanters, Leona Hakkaart
exaly  

Orphan diseases and orphan drugs

Food and Chemical Toxicology, 1987
openaire   +1 more source

Orphan Drugs

2009
Meijer, I., Vos, R., de Jong-van den Berg, L.T.W., Meijer, D.K.F.   +3 more
openaire   +3 more sources

Orphan drugs and rare diseases: a scientometric review (2000 – 2014)

Expert Opinion on Orphan Drugs, 2014
Chaomei Chen
exaly  

Orphan diseases and Orphan drugs

Journal of Pharmaceutical Sciences, 1988
openaire   +1 more source